Methotrexate-cytarabine-dexamethasone combination chemotherapy with or without rituximab in patients with primary central nervous system lymphoma

PURPOSE: High-dose methotrexate based chemotherapy is the standard treatment for patients with newly diagnosed primary central nervous system lymphoma (PCNSL). The role of rituximab is controversial because of its large size, which limits its penetration of the blood-brain barrier. In this study, we...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Sun, Xuefei, Liu, Jing, Wang, Yaming, Bai, Xueyan, Chen, Yuedan, Qian, Jun, Zhu, Hong, Liu, Fusheng, Qiu, Xiaoguang, Sun, Shengjun, Ji, Nan, Liu, Yuanbo
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2017
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5564757/
https://ncbi.nlm.nih.gov/pubmed/28467782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17101
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi